Table 1.
Age, mean ± SD | 54.1 ± 15.4 n=20 |
Gender, % female | 35.0% (7/20) |
Ethnicity, % | |
Black | 35.0% (7/20) |
White | 50.0% (10/20) |
Hispanic | 15.0% (3/20) |
Asian | 0% (0/20) |
Symptoms, % | |
Headache | 45.0% (9/20) |
Vertigo | 30.0% (6/20) |
Nausea | 30.0% (6/20) |
Ataxia | 25.0% (5/20) |
Confusion | 20.0% (4/20) |
Blurred vision | 20.0% (4/20) |
Sensory disturbance | 15.0% (3/20) |
Limb weakness | 10.0% (2/20) |
Double vision | 5.0% (1/20) |
Glucose, median (range) | 128 (83–289) n=20 |
Treated with IV tPA | 5.0% (1/20) |
h/o Afib | 6.3% (1/16) |
h/o CAD | 16.7% (3/18) |
h/o DM | 50.0% (9/18) |
h/o HTN | 77.8% (14/18) |
TOAST classification, % | |
Cardioembolic | 30.0% (6/20) |
Large vessel | 15.0% (3/20) |
Small vessel | 20.0% (4/20) |
Cryptogenic | 20.0% (4/20) |
Other | 15.0% (3/20) |
Disposition, % | |
Home | 75.0% (15/20) |
Inpatient rehab | 10.0% (2/20) |
Skilled nursing | 10.0% (2/20) |
Other | 5.0% (1/20) |
mRS at Discharge | |
0 | 35.0% (7/20) |
1 | 30.0% (6/20) |
2 | 10.0% (2/20) |
3 | 15.0% (3/20) |
4 | 5.0% (1/20) |
5 | 5.0% (1/20) |
6 | 0% (0/20) |
LOS, median (range) | 4.5 (2–10) n=20 |